CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P116. A total of 14 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | – | 34,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 90,418 | $25,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 137,756 | $39,000 | 0.00% |
| UBS Group AG | 51,812 | $15,000 | 0.00% |
| Squarepoint Ops LLC | 16,467 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,642 | $7,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 12,387 | $3,000 | 0.00% |
| CITIGROUP INC | 34,200 | $10,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 112,774 | $31,000 | 0.00% |
| Citadel Advisors | 266,279 | $75,000 | 0.00% |